Ethema Health Corporation (GRST)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 15, 2026, 4:00 PM EST
Ethema Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 18.76 | 6.02 | 5.34 | 4.82 | 1.94 | |
Revenue Growth (YoY) | 211.85% | 12.58% | 10.87% | 148.16% | 473.04% |
Cost of Revenue | 9.55 | 3.07 | 2.66 | 1.96 | 0.71 |
Gross Profit | 9.22 | 2.94 | 2.69 | 2.86 | 1.23 |
Selling, General & Admin | 6.62 | 3.81 | 2.73 | 1.83 | 0.9 |
Operating Expenses | 7.43 | 4.28 | 3.23 | 2.37 | 1.23 |
Operating Income | 1.78 | -1.33 | -0.54 | 0.49 | 0 |
Interest Expense | -2 | -0.98 | -0.78 | -1.21 | -2.8 |
Interest & Investment Income | 0 | 0 | 0 | 0 | - |
Currency Exchange Gain (Loss) | -0.04 | 0.04 | -0.1 | 1.07 | -0.03 |
Other Non Operating Income (Expenses) | 0.07 | 0.11 | -0.14 | 0.02 | 0.95 |
EBT Excluding Unusual Items | -0.19 | -2.17 | -1.56 | 0.36 | -1.88 |
Merger & Restructuring Charges | -2.04 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 2.48 | - | - |
Other Unusual Items | - | - | -0.31 | 0.04 | 0.03 |
Pretax Income | -2.23 | -2.17 | 0.61 | 0.41 | -1.85 |
Income Tax Expense | -0.05 | - | -0.39 | 0.11 | -0.28 |
Earnings From Continuing Operations | -2.18 | -2.17 | 1.01 | 0.3 | -1.57 |
Net Income to Company | -2.18 | -2.17 | 1.01 | 0.3 | -1.57 |
Minority Interest in Earnings | - | 0.1 | 0.17 | -0.05 | 0.03 |
Net Income | -2.18 | -2.06 | 1.18 | 0.25 | -1.54 |
Preferred Dividends & Other Adjustments | - | - | 0.05 | 0.1 | 0.1 |
Net Income to Common | -2.18 | -2.06 | 1.13 | 0.15 | -1.64 |
Net Income Growth | - | - | 374.66% | - | - |
Shares Outstanding (Basic) | 7,727 | 5,609 | 3,729 | 3,705 | 2,702 |
Shares Outstanding (Diluted) | 7,727 | 5,609 | 3,729 | 3,705 | 2,702 |
Shares Change (YoY) | 37.76% | 50.41% | 0.65% | 37.13% | 32.08% |
EPS (Basic) | -0.00 | -0.00 | 0.00 | 0.00 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | 0.00 | 0.00 | -0.00 |
EPS Growth | - | - | 655.00% | - | - |
Free Cash Flow | -0.31 | -0.76 | -5.78 | 1.26 | -0.22 |
Free Cash Flow Per Share | - | - | -0.00 | - | - |
Gross Margin | 49.12% | 48.94% | 50.30% | 59.29% | 63.31% |
Operating Margin | 9.50% | -22.16% | -10.14% | 10.15% | 0.11% |
Profit Margin | -11.61% | -34.30% | 21.13% | 3.11% | -84.60% |
Free Cash Flow Margin | -1.65% | -12.56% | -108.14% | 26.16% | -11.24% |
EBITDA | 2.6 | -0.87 | -0.04 | 1.03 | 0.33 |
EBITDA Margin | 13.83% | -14.39% | -0.80% | 21.35% | 16.86% |
D&A For EBITDA | 0.81 | 0.47 | 0.5 | 0.54 | 0.33 |
EBIT | 1.78 | -1.33 | -0.54 | 0.49 | 0 |
EBIT Margin | 9.50% | -22.16% | -10.14% | 10.15% | 0.11% |
Effective Tax Rate | - | - | - | 27.54% | - |